DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3Dr. Reddy's Laboratories
02 4Alfred E Tiefenbacher GmbH
03 2Breckenridge Pharmaceutical
04 2Bal Pharma
05 2Lee Pharma
06 2ANGITA PHARMA INC.
07 6Accord healthcare
08 4Apotex Inc
09 2Auro Pharma Inc
10 2Aurobindo Pharma Limited
11 2Austell Laboratories
12 2BIOMED 2002 INC
13 2Bionpharma
14 2Bluepharma
15 4Bristol Laboratories Ltd
16 38Bristol Myers Squibb
17 2Cipla Medpro South Africa
18 2Dr Reddy's Laboratories (Pty) Ltd
19 2Dr Seidel Life Science
20 1Eqova
21 1Evertogen
22 2Farmaprojects S.A.U
23 2Hetero Drugs
24 2INNOVATA PHARMACEUTICALS
25 2Impax Laboratories
26 2Indoco Remedies Limited
27 2Intas Pharmaceuticals
28 2JAMP PHARMA
29 2LABORATOIRE RIVA INC.
30 2Laboratorio Eczane Pharma
31 1Laboratorios Lafage
32 2MANTRA PHARMA INC
33 2MARCAN PHARMACEUTICALS INC
34 2MINT PHARMACEUTICALS INC
35 2Macleods Pharmaceuticals Limited
36 2Medichem S.A
37 2Micro Labs Limited
38 2Natco Pharma (Canada) Inc
39 4Nora Pharma
40 2PRO DOC LIMITEE
41 2Pfizer Inc
42 2Pinnacle Life Science
43 1Prinston
44 5Pulse Pharmaceuticals
45 2SANIS HEALTH INC
46 2SIVEM PHARMACEUTICALS ULC
47 4Sandoz B2B
48 1ScieGen Pharmaceuticals
49 2Sigmapharm Laboratories, LLC
50 1Stivaph Healthcare
51 6Sun Pharmaceutical Industries Limited
52 2Sunshine Lake Pharma
53 2Tecnimede
54 3Teva Pharmaceutical Industries
55 2Titan Laboratories
56 4Torrent Pharmaceuticals Limited
57 2Viatris
58 2Wanbang Biopharmaceuticals
59 2Zentiva
60 1Zhejiang Yongning Pharmaceutical Co., Lt
61 2Zydus Pharmaceuticals
Reset all filters
01 11Antic-calc Tablet, Film Coated
02 1Apixaban 2,5Mg 10 Units Oral Use
03 1Apixaban 2,5Mg 20 Joined' Oral Use
04 1Apixaban 2,5Mg 60 Units Oral Use
05 1Apixaban 5Mg 28 Combined Oral Use
06 1Apixaban 5Mg 60 Units Oral Use
07 2Coated Tablet
08 1Each Coated Tablet
09 14FCT
10 2FILM COATED PILL
11 1FOR SUSPENSION;ORAL
12 10Film Coated Tablet
13 2Film Coated Tablet
14 7Film-Coated Tablets
15 2Oral Solid Dosage Form
16 1SUSPENSION;ORAL
17 2TAB
18 40TABLET
19 1TABLET, FOR SUSPENSION;ORAL
20 6TABLET; ORAL
21 35TABLET;ORAL
22 24Tablet
23 2Tablets
24 3tablet
25 5Blank
Reset all filters
01 20DISCN
02 4EU Dossier Readiness-Q4 2018
03 14Generic
04 2Lead Market Dossiers- Filed
05 2Originator
06 10RX
07 124Blank
Reset all filters
01 2ACH-APIXABAN
02 2AG-APIXABAN
03 41APIXABAN
04 1APIXABAN 2,5 DRL
05 1APIXABAN 5 DRL
06 2APO-APIXABAN
07 2AURO-APIXABAN
08 6Apixaban
09 1Apixaban 2,5 Accord
10 1Apixaban 5 Accord
11 2BIO-APIXABAN
12 1Deksel CD
13 10ELIQUIS
14 1ELIQUIS SPRINKLE
15 1EPLIPIX 2,5
16 1EPLIPIX 5
17 5Eliqs
18 26Eliquis
19 1Eliquis 2.5 mg
20 1Eliquis 5 mg
21 2Emboxan
22 1Fibranix 2,5
23 1Fibranix 5
24 1INNOKLOD 2,5
25 1INNOKLOD 5
26 2JAMP APIXABAN
27 2M-APIXABAN
28 2MAR-APIXABAN
29 2MINT-APIXABAN
30 2NAT-APIXABAN
31 2NRA-APIXABAN
32 2NRA-APIXABAN TABLETS
33 1PIXECLOT 2.5 mg
34 1PIXECLOT 5 mg
35 2PRO-APIXABAN
36 2RIVA APIXABAN
37 1Regrenor
38 2SANDOZ APIXABAN SDZ
39 2TARO-APIXABAN
40 2TEVA-APIXABAN
41 2Thromboxan
42 2Xanza
43 1Xarpix 2,5
44 1Xarpix 5
45 29Blank
Reset all filters
01 2Argentina
02 8Australia
03 40Canada
04 2China
05 2Czech Republic
06 6Germany
07 1Guatemala
08 22India
09 5Italy
10 11Norway
11 4Portugal
12 16South Africa
13 4Spain
14 2Sweden
15 7Switzerland
16 44USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET; ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number : 210082
Regulatory Info :
Registration Country : USA
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q4 2018
Registration Country : Germany
Regulatory Info : DISCN
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 2.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
Regulatory Info :
Registration Country : India
Brand Name : Apixaban
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2012-12-28
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ELIQUIS
Dosage Form : TABLET, FOR SUSPENSION;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2025-04-17
Application Number : 202155
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-02-14
Application Number : 209810
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : APIXABAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2020-09-11
Application Number : 209898
Regulatory Info : RX
Registration Country : USA